Envejecimiento cerebral normal y patológico …
535
34: Tolnay, M.; Calhoun, M.; Pham, H. C.; Egensperger, R.; Probst. A Low amyloid (Abeta)
plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain
disease from Alzheimer's disease. Neuropathol Appl Neurobiol
25
, 295-‐305 (1999).
35: Ince, P.; Irving, D.; MacArthur, F.; Perry, R. H. Quantitative neuropathological study of
Alzheimer-‐type pathology in the hippocampus: comparison of senile dementia of
Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-‐
demented elderly control patients. J Neurol Sci.
106
,142-‐152 (1991).
36 Mesulam, M. M.; Weintraub, S.; Rogalski, E. J.; Wieneke, C.; Geula, C.; Bigio, E. H. Asymmetry
and heterogeneity of Alzheimer's and frontotemporal pathology in primaryprogressive
aphasia. Brain (en prensa) (2014).
37. Panza, F.; Frisardi, V.; Capurso, C.; D'Introno, A.; Colacicco, A. M.; Imbimbo, B. P.; Santamato,
A.; Vendemiale, G.; Seripa, D.; Pilotto, A.; Capurso, A.; Solfrizzi, V.; Late-‐life depression, mild
cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatr
18,
98-‐
116 (2010).
38. Wadsworth, L.P.; Lorius, N.; Donovan, N.J.; Locascio, J. J.; Rentz, D. M.; Johnson, K. A.;
Sperling, R. A.; Marshall, G.A. Neuropsychiatric symptoms and global functional
impairment along the Alzheimer's continuum. Dement Geriatr Cogn Disord
34
, 96-‐111
(2012).
39. Zhang, M.; Wang, H.; Li, T.; Yu, X. Prevalence of neuropsychiatric symptoms across the
declining memory continuum: an observational study in a memory clinic setting. Dement
Geriatr Cogn Dis Extra
2
, 200-‐208 (2012).
40. Rami, L.; Fortea, J.; Bosch, B.; Solé-‐Padullés, C.; Lladó, A.; Iranzo, A.; Sánchez-‐Valle, R.;
Molinuevo, J. L. Cerebrospinal fluid biomarkers and memory present distinct associations
along the continuum from healthy subjects to AD patients. J Alz Dis
23
, 319-‐26 (2011).
41. Hyman, B. T.; Phelps, C. H.; Beach, T. G.; Bigio, E. H.; Cairns, N. J.; Carrillo, M. C.; Dickson, D.
W.; Duyckaerts, C.; Frosch, M. P.; Masliah, E.; Mirra, S. S.; Nelson, P. T.; Schneider, J.A.; Thal,
D.R.; Thies, B.; Trojanowski, J. Q.; Vinters, H.V., Montine, T.J. National Institute on Aging-‐
Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's
disease. Alzheimers Dement. Dis.
8
, 1-‐13 (2012).
42. Town, T.; Nikolic, V.; Tan, J. The microglial "activation" continuum: from innate to adaptive
responses. J Neuroinflammation
31
, 2-‐24 (2005).
43. Thal, D. R.; Rüb, U.; Orantes, M.; Braak, H. Phases of Abeta deposition in the human brain
and its relevance for the development of AD. Neurology
58
, 1791-‐1800 (2002).
44. Braak, H.; Braak, E. Neuropathological stageing of Alzheimer-‐related changes. Acta
Neuropathol
82
, 239-‐259 (1991).
45. Nelson, P. T.; Alafuzoff, I.; Bigio, E. H.; Bouras, C.; Braakm, H.; Cairns, N. J:, Castellani, R. J.;
Crain, B. J.; Davies, P.; Del Tredici, K.; Duyckaerts, C.; Frosch, M. P.; Haroutunian, V.; HofPR.;
Hulette, C.M.; Hyman, B.T.; Iwatsubo, T.; Jellinger, K. A.; Jicha, G. A.; Kövari, E.; Kukull, W. A.;
Leverenz, J. B.; Love, S.; Mackenzie, I. R.; Mann, D. M.; Masliah, E.; McKee, A. C.; Montine, T.
J.; Morris, J. C.; Schneider, J. A.; Sonnen, J. A.; Thal, D. R.; Trojanowski, J. Q.; Troncoso, J. C.;
Wisniewski, T.; Woltjer, R. L.; Beach, T. G. Correlation of Alzheimer disease
neuropathologic changes with cognitive status: a review of the literature. J Neuropathol
Exp Neurol
71
, 362-‐381 (2012).
46. Josephs, K. A.; Whitwell, J. L.; Ahmed, Z.; Shiung, M. M.; Weigand, S. D.; Knopman, D. S.;
Boeve, B. F.; Parisi, J. E.; Petersen, R. C.; Dickson, D. W.; Jack, C.R.; Jr. Beta-‐amyloid burden
is not associated with rates of brain atrophy. Ann Neurol
63
, 204-‐12 (2008).
47 Toga, A. W. The clinical value of large neuroimaging data sets in Alzheimer's disease.
Neuroimaging Clin N Am
22
, 107-‐118 (2012).
48. Wirth, M.; Villeneuve, S.; Haase, C. M.; Madison, C. M.; Oh, H.; Landau, S. M.; Rabinovici, G. D.;
Jagust, W. J. Associations between Alzheimer disease biomarkers, neurodegeneration, and
cognition in cognitively normal older people. JAMA Neurol.
70
,1512-‐1519 (2013)
49. Panza, F.; Frisardi, V.; Capurso, C.; D'Introno, A.; Colacicco, A. M.; Chiloiro, R.; Dellegrazie; F.;
Di Palo, A.; Capurso, A.; Solfrizzi, V. Effect of donepezil on the continuum of depressive
symptoms, mild cognitive impairment, and progression to dementia. J Am Geriatr Soc
58
,
389-‐390 (2010).
50. Wright, L. K.; Litaker, M.; Laraia, M. T.; DeAndrade, S. Continuum of care for Alzheimer's
disease: a nurse education and counseling program. Issues Ment Health Nurs
22
, 231-‐252
(2001).
